BCM
CTSO icon

Bluefin Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Bluefin Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,755
Closed -$77K – 521
2015
Q4 		$77K Buy
+13,755
New +$93.7K 0.01% 480

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bluefin Capital Management's CTSO Position: Q1 2016 in Review

Bluefin Capital Management sold out of Cytosorbents Corp (CTSO) in Q1 2016, closing a stake of 13,755 shares — an estimated $77K sold.

Bluefin Capital Management first reported a position in CTSO in Q4 2015 and held it in 1 quarter. The position peaked at $77K in Q4 2015. 33 funds tracked by Wall St. Rank hold CTSO as of Q1 2016.

  • Bluefin Capital Management reported no remaining Cytosorbents Corp position as of Q1 2016 after selling out during the quarter.
  • Bluefin Capital Management sold 13,755 Cytosorbents Corp shares in Q1 2016, an estimated $77K.
  • Bluefin Capital Management first reported a position in Cytosorbents Corp in Q4 2015 and held it in 1 quarter.
  • Bluefin Capital Management's Cytosorbents Corp position peaked at $77K in Q4 2015.
  • 33 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2016.

Based on Bluefin Capital Management's 13F filing for Q1 2016, filed 16 May 2016.